By olkin Friday, November 13, 2020 Business IN FOCUS: After COVID-19, where are the Singapore economy, workforce headed? - CNA SINGAPORE: Recession. Retrenchments. Reskilling. As COVID-19 has ripped through the Singapore economy, such words have become part of daily...
By olkin Thursday, November 12, 2020 Business Stocks to watch: SIA, SATS, ComfortDelGro, Golden Agri, OUE C-Reit, Metro, UMS - Business Times Fri, Nov 13, 2020 - 8:59 AM THE following companies saw new developments that may affect trading of their shares on Friday: Singapore ...
By olkin Thursday, November 12, 2020 Business Fresh vaccine hope as world tops 10000 daily COVID-19 deaths - CNA LONDON: Top US government scientist Anthony Fauci said on Thursday (Nov 12) the coronavirus vaccine "cavalry" was on its way, brin...
By olkin Thursday, November 12, 2020 Business Singapore Airlines raises S$850 million through convertible bond issue - CNA SINGAPORE: Singapore Airlines (SIA) has raised S$850 million through a convertible bond issue, announced the national airline on Friday (No...
By olkin Thursday, November 12, 2020 Business Chinese President Xi Jinping decided to halt Ant's IPO, reports Wall Street Journal - The Straits Times NEW YORK (REUTERS) - China's President Xi Jinping personally decided to pull the plug on Ant Group's US$37 billion (S$50 billion) i...
By olkin Wednesday, November 11, 2020 Business China tech selloff deepens to US$203b after antitrust rules - The Business Times Wed, Nov 11, 2020 - 11:02 AM [BEIJING] Chinese technology shares tumbled for a second day after Beijing clamped down on the Internet in...
By olkin Wednesday, November 11, 2020 Business Singapore's Zouk to open an integrated resort in Las Vegas in 2021 - CNA [unable to retrieve full-text content] Singapore's Zouk to open an integrated resort in Las Vegas in 2021 CNA Zouk to open in Las ...
By olkin Wednesday, November 11, 2020 Business Commentary: Pfizer reaches COVID-19 vaccine breakthrough – a step closer to pandemic's end - CNA CORK, Ireland: Preliminary data from the Pfizer/BioNTech COVID-19 vaccine trial suggests it provides 90 per cent efficacy at preventing the...